Fullerton Health, a prominent healthcare solutions provider in the Asia-Pacific region, has announced that Mitsubishi Corporation has acquired a strategic minority stake in the company. This investment is set to enhance Fullerton Health’s focus on regional growth and accelerate its vision for integrated, digitally enabled healthcare services.
The investment from Mitsubishi Corporation concludes a series of minority investments, including one from Far East Drug. It will support Fullerton Health’s expansion in its key markets—Singapore, Indonesia, and the Philippines—whilst facilitating entry into new markets across the region. The company plans to leverage its extensive network and digital capabilities to deliver comprehensive healthcare solutions.
Ho Kuen Loon, Group CEO and Non-executive Director of Fullerton Health, stated, “This partnership reflects strong alignment between Mitsubishi Corporation and our existing shareholders on the long-term value and industry leadership potential of Fullerton Health. With a shared commitment to impact and innovation, we are well positioned to achieve our aim to positively impact 10 million lives in coming years.”
BofA Securities served as the sole financial adviser for this transaction. Established in 2010, Fullerton Health operates nearly 500 clinics and collaborates with over 18,000 providers across the Asia-Pacific region, offering a wide range of healthcare services from primary care to diagnostics and speciality services.
This strategic investment by Mitsubishi Corporation is expected to strengthen Fullerton Health’s market leadership and enhance its ability to deliver value to stakeholders, aligning with its mission of providing seamless, accessible, and trusted healthcare.
“`
